menu search

Is invesco biotechnology & genome etf (pbe) a strong etf right now?

A smart beta exchange traded fund, the Invesco Biotechnology & genome ETF (PBE) debuted on 06/23/2005, ...

October 31, 2023, 7:31 am

Beam to reprioritize portfolio, slash jobs, shares tank

BEAM announces a restructuring and portfolio reprioritization plan to focus on genome-editing candidate...

October 20, 2023, 12:47 pm

Intellia therapeutics receives priority medicines (prime) designation from the european medicines agency for ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioe

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage ...

October 13, 2023, 12:38 pm

Intellia therapeutics receives priority medicines (prime) designation from the european medicines agency for ntla-2002, an investigational in vivo crispr genome editing treatment for hereditary angioe

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage ...

October 13, 2023, 12:38 pm

Bear of the day: illumina (ilmn)

Illumina ( ILMN ), the maker of million-dollar genome sequencing machines that revolutionized the field...

October 9, 2023, 7:31 am

Vor bio to participate in upcoming investor conferences

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome...

September 25, 2023, 8:00 am

Eric kmiec, ph.d., named editor-in-chief of gene and genome editing

Wilmington, Delaware, Sept. 06, 2023 (GLOBE NEWSWIRE) — Eric Kmiec, Ph.D., executive director and chief scientific officer of ChristianaCare’s Gen...

September 6, 2023, 5:05 pm

Should you invest in the invesco biotechnology & genome (pbe)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the Invesco Biotechnology & ...

September 6, 2023, 7:31 am

Oxford nanopore tightens guidance, analysts remain sceptical

Oxford Nanopore Technologies PLC (LSE:ONT) analysts are still doubtful about the DNA sequencing company's medium-term guidance despite narrowing fu...

September 6, 2023, 6:56 am

Caribou biosciences to participate in upcoming investor conferences

BERKELEY, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR ...

August 29, 2023, 4:00 pm

Genedx announces data demonstrating that whole exome and genome sequencing report fewer variants of uncertain significance (vus) than multi-gene panel testing published in genetics in medicine

STAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, tod...

August 21, 2023, 11:00 am

Is invesco dynamic biotechnology & genome etf (pbe) a strong etf right now?

Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Dynamic Biotechnology & ...

August 17, 2023, 8:01 am

Illumina stock falls, as ‘cautious consumer backdrop' tempers outlook

Shares of Illumina Inc. slid 6.6% after hours on Wednesday after the DNA-sequencing company tempered its full-year sales outlook, amid a cautious cons...

August 9, 2023, 5:09 pm

Pacbio (pacb) inks research collaboration for genome sequencing

PacBio (PACB) and GeneDx sign a deal with the University of Washington to study long-read sequencing in rare diseases. The study will use PacBio's Rev...

August 9, 2023, 9:58 am

Intellia therapeutics to hold conference call to discuss second quarter 2023 earnings and company updates

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage ...

July 27, 2023, 7:30 am

Editas medicine announces second quarter 2023 results conference call and corporate update

CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage ge...

July 26, 2023, 11:00 am

Caribou biosciences offers more stock, and shares fall

Shares of Caribou Biosciences Inc. CRBU, +4.90% tumbled 9.7% after hours on Thursday after the biopharma company said it had begun a $100 million shar...

July 13, 2023, 4:48 pm

Caribou biosciences stock soars after pfizer buys stock priced at a 31% premium

Shares of Caribou Biosciences Inc. CRBU ran up 21.3% toward a three-month high in premarket trading Thursday, after the ...

July 6, 2023, 8:19 am

Should you invest in the invesco dynamic biotechnology & genome etf (pbe)?

Launched on 06/23/2005, the Invesco Dynamic Biotechnology & genome ETF (PBE) is a passively managed exc...

July 3, 2023, 7:42 am

Editas medicine announces pricing of offering of common stock

CAMBRIDGE, Mass., June 14, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage ge...

June 15, 2023, 2:06 am


Search within

Pages Search Results: